> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Comments Extended on Biosimilar Guidance
- URL: https://www.fdaweb.com/comments-extended-on-biosimilar-guidance/
- Published: 2016-06-06T12:00:00.000Z
- Updated: 2026-09-14T21:07:43.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5135853

*Federal Register* Notice: FDA is extending the comment period for a 4/4 Federal Register notice on a draft guidance entitled *Labeling for Biosimilar Products; Draft Guidance for Industry*. Comments should be submitted by 8/2\. To view this notice, click [here.](https://www.gpo.gov/fdsys/pkg/FR-2016-06-06/pdf/2016-13223.pdf?ref=fdaweb.com)